Atossa Therapeutics ATOS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 5.26 | -1.11 | -9,870 | -10 | ||
| 2025Q4 | 8.85 | 104.56 | -1.34 | -11,436 | -11 | |
| 2025Q3 | 13 | 106.43 | -0.9 | -9,251 | -9 | |
| 2025Q2 | 12.45 | 107.33 | -1.05 | -9,040 | -8 | |
| 2025Q1 | 10.09 | 110.36 | -0.75 | -7,414 | -7 | |
| 2024Q4 | 14.16 | 112.67 | -0.75 | -7,151 | -6 | |
| 2024Q3 | 22.8 | 88.3 | -0.75 | -6,384 | -7 | |
| 2024Q2 | 17.85 | 117.47 | -0.75 | -7,106 | -6 | |
| 2024Q1 | 27 | 118.75 | -0.75 | -6,980 | -6 | |
| 2023Q4 | 13.2 | 116.31 | -0.9 | -9,019 | -8 | |
| 2023Q3 | 11.05 | 119.87 | -0.75 | -7,467 | -6 | |
| 2023Q2 | 18.9 | 79.28 | -1.2 | -7,793 | -10 | |
| 2023Q1 | 10.87 | 113.01 | -0.75 | -7,098 | -6 | |
| 2022Q4 | 7.93 | 108.64 | -0.9 | -8,138 | -7 | |
| 2022Q3 | 12.5 | 102.41 | -0.9 | -8,205 | -8 | |
| 2022Q2 | 16.35 | 98.95 | -0.75 | -6,601 | -7 | |
| 2022Q1 | 18.75 | 99.19 | -0.6 | -4,747 | -5 | |
| 2021Q4 | 24 | 99.92 | -0.6 | -4,828 | -5 | |
| 2021Q3 | 48.9 | 99.27 | -0.6 | -5,159 | -5 | |
| 2021Q2 | 94.8 | 99.49 | -0.9 | -7,003 | -7 |